Adar Poonawalla, ‘Y’ rank security for Serum Institute head Adar Poonawalla News Bangalore News by Bengaluru News - April 29, 2021April 29, 20211 Highlights: Y range security for Adar Poonawalla Adar Poonawalla is the head of the Serum Institute Increased background security for company transactions Bengaluru: The central government has provided ‘Y’ rank security to the head of vaccine manufacturer Pune Pune’s Serum Institute of India (SII), Adar Poonawalla, who plays a significant role in the coronavirus vaccine campaign in the country. SII is under pressure to boost vaccine production by several pharma companies, including AstraZeneca and CovieShield, which have been investigated by Oxford VV. The company’s turnover has also increased. The Ministry of Home Affairs has issued a directive to provide security for the category, aware of the potential dangers. Two commandos and one police officer, along with 11 personnel, will provide security. Side effect is sure to be minimal! New Delhi: Only one in four people vaccinated by CoviShield and Pfizer, AstraZeneca-Oxford research, had mild side effects. They all last only 2-3 days. Vaccines are effective in combating corona, according to a study report published in the journal Lancet Infectious Diseases. A team of researchers from King’s College London has compiled a report on the data collected through AAP. The severity of side effects increases within the first 24 hours after vaccination, and then within 2-3 days. Minor side effects may include headaches, fatigue, mild fever, my hand pain. However, the report found that immunization increased the risk of infection to a large extent, reducing the risk of infection. The Pfizer vaccine was administered on the 21st day after receiving the first dose. With a 58 percent reduction in infection risk, the shield vaccine is 39 percent. Risk of infection at least 21 days after the first dose of Pfizer. The risk of infection is reduced by 69% and at least 21 days after the first dose of CovShield. The study reports that the vaccines are currently very successful. It is revealed that the data came from analyzing data from 6.27 lakh people who received both vaccines from December 8 to March 10. .